Morningside Venture Investments Ltd, 10% Owner at Amylyx Pharmaceuticals, Inc. (AMLX), sold 198,889 shares at $35.55 ($7.1M) on 2023-02-23, disclosed to the SEC on 2023-02-24.
Open-market sale of $7.1M AMLX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.91 | 39,916 | $1.4M | 20.1% |
| 2 | $35.91 | 39,916 | $1.4M | 20.1% |
| 3 | $36.34 | 10,084 | $366K | 5.1% |
| 4 | $36.34 | 10,084 | $366K | 5.1% |
| 5 | $35.55 | 48,889 | $1.7M | 24.4% |
| 6 | $35.55 | 48,889 |
| $1.7M |
| 24.4% |
| 7 | $36.24 | 1,111 | $40K | 0.6% |
| Total | $35.78 avg | 198,889 | $7.1M | 100% |
| Filing → |
| AMLX | SELL | 2023-03-29 | $4.9M | — | Filing → |
| AMLX | SELL | 2023-03-23 | $4.0M | — | Filing → |
| AMLX | SELL | 2023-03-17 | $594K | — | Filing → |